Respiratorius AB

Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Created with Highstock 6.0.7CloseTraded Volume17. feb24. feb3. mar10. mar17. mar24. mar31. mar7. apr21. apr28. apr5. maj12. maj4567808T16T24T32T

Right Now

+/-
0.04
%
0,90%
Latest
4.48
High
4.49
Low
4.23
Volume
6 030
Turnover (SEK)
27 005
Market Value (MSEK)
22,8
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Johan Drott
  • Kristina Drott
  • Mia Lundblad
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    Johan Drott, CEO Respiratorius

    Presentation Stora Aktiedagen Stockholm 2017-11-13

    Johan Drott CEO presenterar på Life Science Day 2019

    Johan Drott CEO, presenterar på Redeye Investor Forum - 10 sep

    Johan Drott, CEO Respiratorius

    Presentation Stora Aktiedagen Stockholm 2017-11-13

    Johan Drott CEO presenterar på Life Science Day 2019

    Johan Drott CEO, presenterar på Redeye Investor Forum - 10 sep

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 9,29 9,29 2025-03-27
    Valcuria Holding AB 3,61 3,61 2025-03-27
    Hans Mandahl 2,09 2,09 2025-03-27
    Nicholas Peebo 1,54 1,54 2025-03-27
    Hartmut Wiese 1,45 1,45 2025-03-27
    Göran Lennart Rehn 1,37 1,37 2025-03-27
    Försäkringsaktiebolaget Skandia 1,08 1,08 2025-03-27
    Ben Hayes 1,03 1,03 2025-03-27
    Hans Harvig 0,99 0,99 2025-03-27
    Mattias Nilsson 0,95 0,95 2025-03-27
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    NameTransaction DateTypeInstrumentAmountPriceValueCurrency
    Drott Development2024-12-06Buy TransactionRespiratorius 1 12000,0SEK
    Drott Development2024-11-20Sell TransactionRespiratorius- 348 0000−0,0SEK
    Valcuria Holding AB2024-06-20en-USRESP BTU- 1 020 4080,49−499 999,9SEK
    Valcuria Holding AB2024-06-20en-USRESP BTU 1 020 4080,49499 999,9SEK
    Drott Development2024-06-20en-USRespiratorius BTU 100 0000,4949 000,0SEK
    Drott Development2024-06-20en-USRespiratorius BTU- 100 0000,49−49 000,0SEK
    Niklas Prager2022-04-01en-USRespiratorius TR- 171 7490−0,0SEK
    Niklas Prager2022-04-01en-USRespiratorius 62 9640,5735 889,5SEK
    Valcuria Holding AB2022-04-01en-USRespiratorius 355 3000,57202 521,0SEK
    Johan Drott2022-04-01en-USRespiratorius 355 3000,57202 521,0SEK
    Drott Development2021-07-05en-USRespiratorius 125 0001,2150 000,0SEK
    Johan Drott2021-07-05en-USRespiratorius TO 1- 125 0000−0,0SEK
    Christer Fåhraeus2020-12-16Sell TransactionRespiratorius- 700 0002,8−1 960 000,0SEK
    Christer Fåhraeus2020-06-16en-USRespiratorius 1 168 0640,8934 451,2SEK
    Christer Fåhraeus2020-06-16en-USRespiratorius- 11 680 6400−0,0SEK
    Drott Development AB2020-06-16en-USRespiratorius BTU 125 0001,6200 000,0SEK
    Christer Fåhraeus2020-06-12Buy TransactionRespiratorius 11 680 6430,01116 806,4SEK
    Christer Fåhraeus2020-06-12Sell TransactionRespiratorius- 20 564 3620,01−205 643,6SEK
    Olov Sterner2020-06-12Sell TransactionRespiratorius- 402 1780,02−8 847,9SEK
    Christer Fåhraeus2019-07-19Sell TransactionRespiratorius- 4 000 0001,8−7 200 000,0SEK
    Anders Månsson2018-01-31en-USRespiratorius 25 6971,230 836,4SEK
    Johan Drott2017-12-20Buy TransactionRespriatorius AB 465 4521,2558 542,4SEK
    Christer Fåhraeus2017-12-27Buy TransactionRespiratorius AB 2 729 2621,23 275 114,4SEK
    Anders Månsson2017-03-24Buy TransactionRespiratorius AB 21 5172,3249 919,4SEK
    Lars Christer Fredrik Fåhraeus2017-01-16Sell Transactionaktier- 1 185 0001,5−1 777 500,0SEK
    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    2024-12-312024-12-312024-09-302024-06-302024-03-312023-12-312023-12-31
    Number of months that the report spans 2024Q4 3 MonthsQ3 3 MonthsQ2 3 MonthsQ1 3 Months2023Q4 3 Months
    Total revenue MSEK0.000.000.000.000.000.000.00
    Earnings before interest and tax MSEK-7.51-1.87-2.08-1.81-1.76-7.83-2.45
    Profit before tax MSEK-7.57-1.87-2.13-1.81-1.76-7.83-2.45
    Net profit MSEK-7.57-1.87-2.13-1.81-1.76-7.83-2.45
    Earnings per share SEK-0.00-0.00-0.00-0.00-0.00-0.00-0.00
    Dividend per share SEK0.000.00
    Equity MSEK30.1030.1032.1824.8524.7426.5026.50
    Fixed assets MSEK0.000.000.000.000.000.000.00
    Intangible assets MSEK23.0423.0423.4524.1124.9125.5725.57
    Current assets MSEK7.977.979.423.050.882.232.23
    Total asset MSEK31.0231.0232.8827.1725.8027.8927.89
    Long term liabilities MSEK0.000.000.000.000.000.000.00
    Current liabilities MSEK0.920.920.692.321.051.291.29
    Number of shares SEK5.105.10509.85292.32292.32292.32292.32
    *Compiled data from Millistream

    Upcoming reports

    • 2025-05-21 Årsstämma 2024

    • 2025-05-21 Delårsrapport 2025-Q1

    • 2025-08-12 Delårsrapport 2025-Q2

    • 2025-11-11 Delårsrapport 2025-Q3

    • 2026-02-10 Bokslutskommuniké 2025

    Annual reports, prospectus etc.